News | September 07, 2022
Lupin and DKSH sign licensing and supply agreement to market five biosimilar candidates in the Philippines
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
